Insulet Corp (PODD) stock
PODDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 21/3048% below fair value
$139.98−5.36 (-3.69%)
Close on Nov 18, 2026Market cap $9.71BP/E 22.8Yield –
Insulet gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Insulet's gross profit for the twelve months ending Sep 30, 2026 was $2.29B, up 27.2% year over year. For fiscal 2025 it was $1.94B, up 34.2% from the year before. Over ten years it grew 30.7% a year on average. The highest annual figure on record is $1.94B in fiscal 2025.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.94B | +34.2% |
| FY2024 | Dec 31, 2024 | $1.45B | +24.6% |
| FY2023 | Dec 31, 2023 | $1.16B | +44.0% |
| FY2022 | Dec 31, 2022 | $805.60M | +7.1% |
| FY2021 | Dec 31, 2021 | $752.10M | +29.2% |
| FY2020 | Dec 31, 2020 | $582.30M | +21.2% |
| FY2019 | Dec 31, 2019 | $480.30M | +29.7% |
| FY2018 | Dec 31, 2018 | $370.20M | +33.5% |
| FY2017 | Dec 31, 2017 | $277.20M | +31.3% |
| FY2016 | Dec 31, 2016 | $211.09M | +58.4% |
| FY2015 | Dec 31, 2015 | $133.27M | +4.8% |
| FY2014 | Dec 31, 2014 | $127.13M | +13.1% |
| FY2013 | Dec 31, 2013 | $112.40M | +21.7% |
| FY2012 | Dec 31, 2012 | $92.34M | +38.4% |
| FY2011 | Dec 31, 2011 | $66.71M | +52.6% |
| FY2010 | Dec 31, 2010 | $43.73M | +139.0% |
| FY2009 | Dec 31, 2009 | $18.30M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $632.10M | +23.9% |
| Q2 FY2026 | Jun 30, 2026 | $562.60M | +24.4% |
| Q1 FY2026 | Mar 31, 2026 | $529.10M | +29.4% |
| Q4 FY2025 | Dec 31, 2025 | $568.60M | +32.0% |
| Q3 FY2025 | Sep 30, 2025 | $510.10M | +35.3% |
| Q2 FY2025 | Jun 30, 2025 | $452.20M | +36.7% |
| Q1 FY2025 | Mar 31, 2025 | $409.00M | +33.3% |
| Q4 FY2024 | Dec 31, 2024 | $430.90M | +19.3% |
| Q3 FY2024 | Sep 30, 2024 | $377.10M | +28.6% |
| Q2 FY2024 | Jun 30, 2024 | $330.90M | +24.9% |
| Q1 FY2024 | Mar 31, 2024 | $306.80M | +27.6% |
| Q4 FY2023 | Dec 31, 2023 | $361.20M | +66.2% |
| Q3 FY2023 | Sep 30, 2023 | $293.30M | +55.8% |
| Q2 FY2023 | Jun 30, 2023 | $264.90M | +39.2% |
| Q1 FY2023 | Mar 31, 2023 | $240.50M | +14.7% |
| Q4 FY2022 | Dec 31, 2022 | $217.30M | +1.9% |
| Q3 FY2022 | Sep 30, 2022 | $188.30M | -0.2% |
| Q2 FY2022 | Jun 30, 2022 | $190.30M | +4.2% |
| Q1 FY2022 | Mar 31, 2022 | $209.70M | +25.2% |
| Q4 FY2021 | Dec 31, 2021 | $213.20M | +32.3% |
| Q3 FY2021 | Sep 30, 2021 | $188.70M | +24.3% |
| Q2 FY2021 | Jun 30, 2021 | $182.70M | +28.2% |
| Q1 FY2021 | Mar 31, 2021 | $167.50M | +32.0% |
| Q4 FY2020 | Dec 31, 2020 | $161.10M | +20.1% |
| Q3 FY2020 | Sep 30, 2020 | $151.80M | +23.3% |
| Q2 FY2020 | Jun 30, 2020 | $142.50M | +22.4% |
| Q1 FY2020 | Mar 31, 2020 | $126.90M | +18.9% |
| Q4 FY2019 | Dec 31, 2019 | $134.10M | +21.6% |
| Q3 FY2019 | Sep 30, 2019 | $123.10M | +20.7% |
| Q2 FY2019 | Jun 30, 2019 | $116.40M | +41.8% |
| Q1 FY2019 | Mar 31, 2019 | $106.70M | +40.8% |
| Q4 FY2018 | Dec 31, 2018 | $110.30M | +38.7% |
| Q3 FY2018 | Sep 30, 2018 | $102.00M | +38.5% |
| Q2 FY2018 | Jun 30, 2018 | $82.10M | +27.0% |
| Q1 FY2018 | Mar 31, 2018 | $75.80M | +27.6% |
| Q4 FY2017 | Dec 31, 2017 | $79.51M | +30.5% |
| Q3 FY2017 | Sep 30, 2017 | $73.62M | – |
| Q2 FY2017 | Jun 30, 2017 | $64.64M | – |
| Q1 FY2017 | Mar 31, 2017 | $59.40M | – |
| Q4 FY2016 | Dec 31, 2016 | $60.94M | – |
See a number that looks wrong?